消息，根据市场公开信息及10月16日披露的机构调研信息，嘉实基金近期对2家上市公司进行了调研，相关名单如下： 1)信诺维(嘉实基金参与公司特定对象调研&分析师会议) 调研纪要：公司拟自建商业化团队，聚焦核心市场及重点医院，开展创新产品学术推广。注射用亚胺西福(XNW4107)已于2025年6月提交NDA，预计2026年底前获批；EZH2抑制剂XNW5004首项适应症NDA于2026年9月获受理并纳 ...

证券之星消息，根据市场公开信息及10月16日披露的机构调研信息，招商基金近期对1家上市公司进行了调研，相关名单如下：1）信诺维 （招商基金参与公司特定对象调研&分析师会议）调研纪要：公司拟自建商业化团队，聚焦核心市场及重点医院，开展创新产品学术推广。

The performance data shown in tables and graphs on this page is calculated in USD of the fund/index/average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ...

Travere Therapeutics Aktie (NASDAQ: TVTX) und aktueller Kurs 49,60 - dazu Charts, News, Termine und Kursziele zu Travere Therapeutics.

Målet var 200 deltagere, men flere end ventet fandt vej til den første udgave af Gammelbroløbet. Også redaktionens udsendte, ...

A protocol for deprescribing inappropriate medications for patients on hemodialysis was feasible and well received, according ...

The Federal Trade Commission and seven states asked a federal judge Tuesday to hold Martin Shkreli in civil contempt. They ...

Stock market news for October 12, 2026. Press releases, financial news, and business developments from public companies with ...

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) ...

(Nasdaq: TVTX) today announced that on October 10, 2026, the Compensation Committee of its Board of Directors granted ...

So the stock is attached to a real, maturing franchise. The question is what the mRNA platform is worth, and the honest ...